TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for extracorporeal perfusion and preservation of donor hearts; and OCS Liver for the preservation of donor livers. The company was founded in 1998 and is headquartered in Andover, Massachusetts.

TransMedics Group, Inc.

Net Product Revenue

Net Product Revenue %Chg

Net Product Revenue Common Size

Service Revenue

Service Revenue %Chg

Service Revenue Common Size

Total Revenue

Total Revenue %Chg

Total Revenue Common Size

Cost of Net Product Revenue

Cost of Net Product Revenue %Chg

Cost of Net Product Revenue Common Size

Cost of Service Revenue

Cost of Service Revenue %Chg

Cost of Service Revenue Common Size

Total Cost of Revenue

Total Cost of Revenue %Chg

Total Cost of Revenue Common Size

Gross Profit

Gross Profit %Chg

Gross Profit Common Size

Research, Development and Clinical Trials

Research, Development and Clinical Trials %Chg

Research, Development and Clinical Trials Common Size

Acquired in-Process Research and Development Expenses

Acquired in-Process Research and Development Expenses %Chg

Acquired in-Process Research and Development Expenses Common Size

Selling, General and Administrative

Selling, General and Administrative %Chg

Selling, General and Administrative Common Size

Total Operating Expenses

Total Operating Expenses %Chg

Total Operating Expenses Common Size

Income from Operations

Income from Operations %Chg

Income from Operations Common Size

Interest Expense

Interest Expense %Chg

Interest Expense Common Size

Change in Fair Value of Preferred Stock Warrant Liability

Change in Fair Value of Preferred Stock Warrant Liability %Chg

Change in Fair Value of Preferred Stock Warrant Liability Common Size

Interest Income and Other Income (Expense), Net

Interest Income and Other Income (Expense), Net %Chg

Interest Income and Other Income (Expense), Net Common Size

Interest Income and Other Income, Net

Interest Income and Other Income, Net %Chg

Interest Income and Other Income, Net Common Size

Total Other Income (Expense), Net

Total Other Income (Expense), Net %Chg

Total Other Income (Expense), Net Common Size

Total Other Expense, Net

Total Other Expense, Net %Chg

Total Other Expense, Net Common Size

Income Before Income Taxes

Income Before Income Taxes %Chg

Income Before Income Taxes Common Size

(Provision) Benefit for Income Taxes

(Provision) Benefit for Income Taxes %Chg

(Provision) Benefit for Income Taxes Common Size

Net Income

Net Income %Chg

Net Income Common Size

Basic

Basic %Chg

Basic Common Size

Diluted

Diluted %Chg

Diluted Common Size

Total Revenues

Total Revenues %Chg

Total Revenues Common Size

Cost of Sales

Cost of Sales %Chg

Cost of Sales Common Size

Gross Profit Margin

Gross Profit Margin %Chg

Gross Profit Margin Common Size

Selling, General & Administrative Expenses

Selling, General & Administrative Expenses %Chg

Selling, General & Administrative Expenses Common Size

Research & Development Expenses

Research & Development Expenses %Chg

Research & Development Expenses Common Size

Operating Profit

Operating Profit %Chg

Operating Profit Common Size

Operating Margin

Operating Margin %Chg

Operating Margin Common Size

Interest and Investment Income

Interest and Investment Income %Chg

Interest and Investment Income Common Size

Non-Operating Income

Non-Operating Income %Chg

Non-Operating Income Common Size

Total Non-Operating Income

Total Non-Operating Income %Chg

Total Non-Operating Income Common Size

Income Before Provision for Income Taxes

Income Before Provision for Income Taxes %Chg

Income Before Provision for Income Taxes Common Size

Provision for Income Taxes

Provision for Income Taxes %Chg

Provision for Income Taxes Common Size

Consolidated Net Income

Consolidated Net Income %Chg

Consolidated Net Income Common Size

Net Income Attributable to Common Shareholders

Net Income Attributable to Common Shareholders %Chg

Net Income Attributable to Common Shareholders Common Size

Basic EPS

Revenue

EBIT

EBITDA

CapEx

Net Interest Income

Assets

Adjusted EBITDA

Adjusted Net Income

Net Revenue

Average Assets

Adjusted EBIT

Adjusted Revenue

Adjusted EBT

Adjusted Funds From Operations

Income Statement	Jun '25	Dec '24	Jun '24	Dec '23	Jun '23	Dec '22
Total Revenues	300.9	230.4	211.2	147.6	94	57.1
Total Revenues %Chg	42.5%	56.1%	124.6%	158.7%	158.3%	279.4%
Net Product Revenue
Service Revenue
Cost of Sales	116.1	97.5	81.9	59	28.5	18.2
Cost of Net Product Revenue
Cost of Service Revenue
Gross Profit	184.8	132.9	129.2	88.6	65.5	38.8
Gross Profit
Gross Profit Margin	61.4%	57.7%	61.2%	60%	69.7%	68%
Selling, General & Administrative Expenses	87.7	89.6	79.1	65.2	54.3	38.6
Selling, General and Administrative
Research & Development Expenses	33.1	30.7	25.2	49.1	14.2	12.6
Research, Development and Clinical Trials
Acquired in-Process Research and Development Expenses
Operating Profit	64	12.6	24.9	-25.7	-3	-12.3
Income from Operations
Operating Margin	21.3%	5.5%	11.8%	-17.4%	-3.2%	-21.6%
Interest and Investment Income	5.8	9.8	6.8	9.9	3	0
Interest Income and Other Income (Expense), Net
Interest Income and Other Income, Net
Interest Expense	-6.9	-7.2	-7.2	-7.2	-3.6	-1.8
Interest Expense
Non-Operating Income	—	—	—	—	—	—
Change in Fair Value of Preferred Stock Warrant Liability
Total Non-Operating Income	-1.2	2.6	-0.4	2.7	-0.6	-1.8
Income Before Provision for Income Taxes	62.9	11.2	24.5	-23.1	-3.6	-14.1
Income Before Income Taxes
Provision for Income Taxes	2.3	0.2	0.2	-1.7	0	0
(Provision) Benefit for Income Taxes
Consolidated Net Income	60.6	11.1	24.4	-21.4	-3.6	-14.1
Net Income
Net Income Attributable to Common Shareholders	60.6	11.1	24.4	-21.4	-3.6	-14.1
Net Income
Basic EPS	1.8	0.3	0.7	-0.7	-0.1	-0.4
Diluted EPS	1.6	0.3	0.7	-0.7	-0.1	-0.4
Basic Weighted Average Shares Outstanding	33.8	33.5	32.9	32.6	32.4	31.1
Total Shares Outstanding	34	33.6	33.3	32.7	32.6	32.1
Diluted Weighted Average Shares Outstanding	40.2	35.5	35	32.6	32.4	31.1
EBITDA	76.9	23.4	33.8	-20.2	-0.3	-10.1
Effective Tax Rate	3.6%	1.4%	0.6%	7.3%	-0.9%	-0.3%